These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6457169)

  • 21. [Clinical evaluation of 6059-S therapy in children (author's transl)].
    Meguro H; Arimasu O; Matsueda Y; Tohgo T; Hiraiwa M; Ozawa S; Mashiko J; Fujii R
    Jpn J Antibiot; 1981 Apr; 34(4):599-607. PubMed ID: 6457168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fundamental and clinical studies in pediatric field on 6059-S (author's transl)].
    Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Chikaoka H; Oka S; Hirama Y; Narita A
    Jpn J Antibiot; 1981 Apr; 34(4):562-75. PubMed ID: 6457165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of application of CS-1170 to pediatric infections (author's transl)].
    Sohgen S; Yanagisawa K; Ichihashi H
    Jpn J Antibiot; 1979 Jan; 32(1):25-8. PubMed ID: 154583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Basic and clinical examinations of 6059-S in pediatrics (author's transl)].
    Yamashita N; Sunakawa K; Hara N; Nanri S; Morikawa Y; Akita H; Hotta M; Tojo M; Ichihashi Y; Hirose M
    Jpn J Antibiot; 1981 Apr; 34(4):576-86. PubMed ID: 6457166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

  • 27. Moxalactam in the treatment of pediatric infections.
    Yogev R; Schreiber M; Gardner S; Shulman ST
    Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
    Carbon C
    Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacokinetics, in vitro activity and clinical experience with lamoxactam].
    Klech H; Fiser I
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):369-78. PubMed ID: 6221244
    [No Abstract]   [Full Text] [Related]  

  • 30. [Laboratory and clinical studies of 6059-S in pediatric field (author's transl)].
    Nishimura T; Hiromatsu K; Takashima T; Tabuki K; Takagi M
    Jpn J Antibiot; 1981 May; 34(5):800-16. PubMed ID: 6457177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Basic and clinical examinations of CS-1170 in pediatrics (author's transl)].
    Nanri S; Sunakawa K; Hara N; Yamashita N; Akita H; Hotta M; Izeki M; Morikawa Y; Osano M; Ichihashi Y
    Jpn J Antibiot; 1979 Jan; 32(1):18-24. PubMed ID: 370423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics and clinical studies on CS-1170 (author's transl)].
    Nishimura T; Kotani Y; Takashima T; Hiromatsu K
    Jpn J Antibiot; 1979 Feb; 32(2):221-6. PubMed ID: 439393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experience with CS-1170 in gynecological infections (author's transl)].
    Matsuoka I; Shirakawa K
    Jpn J Antibiot; 1979 Mar; 32(3):342-5. PubMed ID: 439404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children.
    Kaplan SL; Mason EO; Kvernland SJ; Loiselle EM; Feigin RD
    Pediatrics; 1983 Feb; 71(2):187-91. PubMed ID: 6218472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical trials of cefmetazole on the bacterial infections of the skin (author's transl)].
    Matsumoto T
    Jpn J Antibiot; 1981 Nov; 34(11):1465-9. PubMed ID: 6950130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental and clinical studies on 6059-S (author's transl)].
    Toyonaga Y; Sugita M; Kurosu Y; Kumagai K; Hori M; Takahashi T
    Jpn J Antibiot; 1981 May; 34(5):764-81. PubMed ID: 6457175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of moxalactam.
    Livingston WK; Elliott AM; Dismukes WE; Avent CK; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jul; 20(1):88-97. PubMed ID: 6456688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Moxalactam in complications of abdominal surgery].
    Dupeyron JP; Peter JD; Rigolot JC
    Sem Hop; 1983 Jun; 59(26):1985-9. PubMed ID: 6310792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and pharmacokinetic evaluation of moxalactam in infants and children.
    Varghese M; Khan AJ; Quaye G; Patel U; Kumar K; Evans HE
    Chemotherapy; 1982; 28(6):417-20. PubMed ID: 6218971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of moxalactam for bacterial meningitis.
    Kaplan SL; Mason EO; Feigin RD
    J Pediatr; 1982 May; 100(5):843. PubMed ID: 6461736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.